NTK

2,3-di(butanoyloxy)propyl butanoate

Find entries where: NTK

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	2,3-di(butanoyloxy)propyl butanoate
Identifiers	2,3-di(butanoyloxy)propyl butanoate
Formula	C₁₅ H₂₆ O₆
Molecular Weight	302.363
Type	NON-POLYMER
Isomeric SMILES	CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC
InChI	InChI=1S/C15H26O6/c1-4-7-13(16)19-10-12(21-15(18)9-6-3)11-20-14(17)8-5-2/h12H,4-11H2,1-3H3
InChIKey	UYXTWWCETRIEDR-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	47
Chiral Atom Count	0
Bond Count	46
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB12709
Name	Tributyrin
Groups	investigational
Description	Tributyrin has been used in trials studying the treatment of Prostate Cancer and Unspecified Adult Solid Tumor, Protocol Specific.
Synonyms	Tributyrin
Categories	Glycerides Lipids
CAS number	60-01-5

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Caspase-3	MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIII...	unknown	activator

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682